Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide
about
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaCellular mechanisms of neuropathic pain, morphine tolerance, and their interactions.PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexesDesign and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.Analgesic efficacy of non-steroidal anti-inflammatory drugs in experimental pain in humansCI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.In my opinion... opioid tolerance.A locus and mechanism of action for associative morphine toleranceDesign and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.Pharmacological strategies in relieving neuropathic pain.Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitorStudies on the conformation, enzymatic degradation, pharmacological potency, and binding properties in brain tissue of cholecystokinin-8 and new related peptides.Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors.Mu opioids and their receptors: evolution of a concept.Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia.The neuroscience of placebo effects: connecting context, learning and health.NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System.Cholecystokinin and pain: a review.Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.Evaluation of a series of novel CCKB antagonists using a functional assay in the rat central nervous systemInduced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.Obviation of opioid withdrawal syndrome by concomitant administration of naltrexone in microgram doses: two psychonautic bioassays.Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization.Reversal of electroacupuncture tolerance by CCK-8 antiserum: an electrophysiological study on pain-related neurons in nucleus parafascicularis of the rat.Lack of Analgesic Synergy of the Cholecystokinin Receptor Antagonist Proglumide and Spinal Cord Stimulation for the Treatment of Neuropathic Pain in Rats.The periaqueductal gray and Bayesian integration in placebo analgesia.
P2860
Q24552584-214FB76F-E87A-4247-805E-00C5799AC1B9Q24650739-6E5B7625-819B-4B19-B11F-D1123B6E91CAQ33679560-ED980E62-2565-46D6-A923-DA4DF16BD24DQ33792380-D6971A66-AA78-4469-9C3D-5E35D2E96D99Q34049320-8DCE9463-D12D-473D-9CBF-5F42C4EA0C0CQ34345634-5B18EC6E-AC10-4E34-AA72-D21CCF8DDEA3Q34466681-F34CB928-E42B-4FC3-98AB-619307B28440Q34618594-C749EBDD-7B28-424F-B0F3-1C2206C375AEQ35082708-1EF79177-733B-41AC-B962-EE8D1375E9D9Q35096042-567E0BC6-2186-4343-B933-4B4CB4928107Q35784044-3521B7F5-89D6-4EE1-B2A5-CD37011878CEQ36341020-91275E3D-11F8-4B9B-B804-CA2EA960E760Q36423695-CEF02596-9E28-4FB5-9AE0-00B435900499Q36591603-B9729312-6132-41D3-8A4D-1D218D6F9E4EQ36628300-39DB1B0E-6EC6-41A1-B343-75A83169027BQ37236111-D7A3E9EA-4231-47E3-8E72-E4EECB0E7677Q37979202-52FB6FDC-8ACC-41F8-B0E8-5588752C35DBQ38531270-75A5757B-1BF2-48AB-9F43-A0E4A6572CDCQ38974282-D3010FC7-DA3C-40DE-A790-B8DFD1BE2DFDQ39448121-47995626-7D0C-45DE-A93D-9C7B40E55CA3Q41531803-7484353E-1025-4280-84EC-00BBFFC98D61Q42075820-8EE5A7E5-28A5-46D6-B4C6-8793A2BB4807Q43169496-0398A9C9-092C-4A4D-AE7F-77D385D01F89Q43518009-21D17539-ED8D-44C7-822B-8B7DB1B9BE75Q44330328-098C4289-7339-4111-9B94-45603BFA426DQ44902293-BF3E4C94-1DB2-44FB-9433-46DC2ADBF388Q48578208-2DB0F000-3504-4CAF-9B88-90ECB94C4F18Q51657500-3AC51198-2E1F-446C-B75A-65F2353C9B64Q54091866-63BFDF4D-9B88-44E5-BD80-680D63CDB5F1Q55263350-26226582-EF0A-45A9-8B3B-DB5D73FBE72D
P2860
Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide
description
1984 nî lūn-bûn
@nan
1984 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Potentiation of opiate analges ...... rphine tolerance by proglumide
@ast
Potentiation of opiate analges ...... rphine tolerance by proglumide
@en
Potentiation of opiate analges ...... rphine tolerance by proglumide
@nl
type
label
Potentiation of opiate analges ...... rphine tolerance by proglumide
@ast
Potentiation of opiate analges ...... rphine tolerance by proglumide
@en
Potentiation of opiate analges ...... rphine tolerance by proglumide
@nl
prefLabel
Potentiation of opiate analges ...... rphine tolerance by proglumide
@ast
Potentiation of opiate analges ...... rphine tolerance by proglumide
@en
Potentiation of opiate analges ...... rphine tolerance by proglumide
@nl
P2093
P356
P1433
P1476
Potentiation of opiate analges ...... rphine tolerance by proglumide
@en
P2093
I B Kinscheck
L R Watkins
P356
10.1126/SCIENCE.6546809
P407
P577
1984-04-27T00:00:00Z